NO940778D0 - Mutert vekstfaktorreseptor som et legemiddel og dets anvendelse til å behandle kreft - Google Patents

Mutert vekstfaktorreseptor som et legemiddel og dets anvendelse til å behandle kreft

Info

Publication number
NO940778D0
NO940778D0 NO940778A NO940778A NO940778D0 NO 940778 D0 NO940778 D0 NO 940778D0 NO 940778 A NO940778 A NO 940778A NO 940778 A NO940778 A NO 940778A NO 940778 D0 NO940778 D0 NO 940778D0
Authority
NO
Norway
Prior art keywords
drug
growth factor
factor receptor
treat cancer
mutant growth
Prior art date
Application number
NO940778A
Other languages
English (en)
Other versions
NO940778L (no
Inventor
Norbert Redemann
Axel Ulrich
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO940778D0 publication Critical patent/NO940778D0/no
Publication of NO940778L publication Critical patent/NO940778L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO940778A 1991-09-05 1994-03-04 Mutert vekstfaktorreseptor som et legemiddel og dets anvendelse til å behandle kreft NO940778L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19914129533 DE4129533A1 (de) 1991-09-05 1991-09-05 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs
PCT/EP1992/002058 WO1993005148A1 (de) 1991-09-05 1992-09-07 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs

Publications (2)

Publication Number Publication Date
NO940778D0 true NO940778D0 (no) 1994-03-04
NO940778L NO940778L (no) 1994-05-04

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940778A NO940778L (no) 1991-09-05 1994-03-04 Mutert vekstfaktorreseptor som et legemiddel og dets anvendelse til å behandle kreft

Country Status (12)

Country Link
EP (1) EP0667899A1 (no)
JP (1) JPH07502884A (no)
CN (1) CN1071586A (no)
AU (1) AU669857B2 (no)
CA (1) CA2117073A1 (no)
DE (1) DE4129533A1 (no)
FI (1) FI941053A (no)
MX (1) MX9205084A (no)
NO (1) NO940778L (no)
NZ (1) NZ244239A (no)
PT (1) PT100844A (no)
WO (1) WO1993005148A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
BRPI0508286B8 (pt) 2004-03-31 2021-05-25 Dana Farber Cancer Inst Inc método para determinar a probabilidade de eficácia de um inibidor da tirosina quinase egfr para tratar câncer, uso de um inibidor da tirosina quinase de egfr, sonda, kit, e, par de iniciadores

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926888T2 (de) * 1988-01-22 1997-01-09 Zymogenetics Inc Verfahren zur Herstellung von sekretierten Rezeptoranalogen
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
DE69031120T2 (de) * 1989-05-19 1998-01-15 Genentech Inc Her2 extrazellulare domäne
WO1991003489A1 (en) * 1989-09-08 1991-03-21 The Johns Hopkins University Structural alterations of the egf receptor gene in human gliomas

Also Published As

Publication number Publication date
WO1993005148A1 (de) 1993-03-18
AU2518592A (en) 1993-04-05
FI941053A (fi) 1994-04-08
EP0667899A1 (de) 1995-08-23
MX9205084A (es) 1993-05-01
CN1071586A (zh) 1993-05-05
DE4129533A1 (de) 1993-03-11
AU669857B2 (en) 1996-06-27
FI941053A0 (fi) 1994-03-04
JPH07502884A (ja) 1995-03-30
CA2117073A1 (en) 1993-03-18
PT100844A (pt) 1994-05-31
NO940778L (no) 1994-05-04
NZ244239A (en) 1995-07-26

Similar Documents

Publication Publication Date Title
NO924768D0 (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
ATA129892A (de) Pharmazeutische zusammensetzung
NO940210D0 (no) Lukke for medikamentbroenn
LV10386A (lv) Farmaceitiska kompozicija un tas pagatavosanas panemiens
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
NO940778D0 (no) Mutert vekstfaktorreseptor som et legemiddel og dets anvendelse til å behandle kreft
DE69205502T2 (de) Stiftzusammensetzung enthaltend Salzsäurenatrium und Stearylalkohol.
DK43489A (da) Immunotoksin og fremgangsmaade til dets fremstilling
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
NO921834L (no) Smerteregulerende sammensetning og fremgangsmaate for fremstilling
AU2299592A (en) Treatment of periodontal disease with protease inhibitors
NO921908D0 (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO179073C (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
ITMI912426A1 (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
KR930012948U (ko) 회전 침대
KR940014425U (ko) 자연석을 이용한 조립식 가열메트리스
GB2260493B (en) Device to administer actives over extended periods
ZA924789B (en) 2-(1-piperidyl)ethanol derivatives,their preparation and their therapeutic application
KR920016351U (ko) 맛사지용 의자
FI980391A0 (fi) Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö
IT8809003A0 (it) Supporto terapeutico per lungodegenti
DE69223962D1 (de) Stuhlmechanismus
KR930008255U (ko) 자동 지압의자
ITAN910030U1 (it) -testiera universale per letti singoli e matrimoniali